Isoxaprolol

This classification denotes a bronchodilator and beta-adrenergic blocking agent with the molecular formula C19H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Y84EU1HAA, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-(2-(2-(3-methyl-5-isoxazolyl)ethenyl)phenoxy)- but generally known as isoxaprolol, which bears US NIH Compound Identifier 6443854. European Medicines Agency schedules Isoxaprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08342MIG. The term ISOXAPROLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). ISOXAPROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isoxaprolol under HS 29349990 and SITC 51579. As of Q4 2014, ISOXAPROLOL remains the US FDA Preferred Term for this commodity. Isoxaprolol bears US NLM identifiers UMLS ID C1881282 and NCI Concept Code C65985. SMILES: OC(CNC(C)(C)C)COC1C(CCCC1)/C=C/C1ONC(C1)C.